Document is current
Any future updates will be listed below
-
Authors
Wong, Kwong-Kwok https://orcid.org/0000-0002-0375-6669
Bateman, Nicholas W.
Ng, Chun Wai
Tsang, Yvonne T. M.
Sun, Charlotte S.
Celestino, Joseph
Nguyen, Tri V.
Malpica, Anais
Hillman, R. Tyler
Zhang, Jianhua
Futreal, P. Andrew
Rojas, Christine
Conrads, Kelly A.
Hood, Brian L.
Dalgard, Clifton L.
Wilkerson, Matthew D.
Phippen, Neil T.
Conrads, Thomas P.
Maxwell, George L.
Sood, Anil K.
Gershenson, David M.
-
Funding
Funding for this research was provided by:
U.S. Army (W81XWH-19-1-0169)
National Cancer Institute (P50CA217685, R35CA209904)
National Cancer Center (P30CA016672)
Uniformed Services University of the Health Sciences (HU0001-16-2-0006)
University of Texas MD Anderson Cancer Center (MD Anderson Ovarian Cancer Moon Shot Program)
Ludemann Family (Low-grade ovarian cancer research)
STAAR Ovarian Cancer Foundation
- License Information
-
More Information
Article History
Received: 5 October 2022
Accepted: 11 December 2022
First Online: 17 December 2022
Declarations
:
: This study was approved by the Institutional Review Board of the University of Texas MD Anderson Cancer Center, and all samples were collected after obtaining written informed consent from patients.
: Not applicable.
: T.P.C. consulted with Thermo Fisher Scientific and received research funding from AbbVie. G.L.M. consulted Merck, Kiyatec, Renovia, and Tesaro, and received research funding from Merck. A.K.S. consults with Merck and Kiyatec, has research funding from M-Trap, and is a shareholder of the BioPath Holdings. All other authors declare that they have no competing interests.
